Journal Article
. 2014 May;().
doi: 10.1016/j.tranon.2014.04.001.

A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2

Shuang Zhao 1 S Laura Chang 2 Jennifer J Linderman 2 Felix Y Feng 3 Gary D Luker 4 
Affiliations
  • PMID: 24836649
  •     63 References
  •     19 citations

Abstract

CXCL12-CXCR4-CXCR7 signaling promotes tumor growth and metastasis in breast cancer. Alternative splicing of CXCL12 produces isoforms with distinct structural and biochemical properties, but little is known about isoform-specific differences in breast cancer subtypes and patient outcomes. We investigated global expression profiles of the six CXCL12 isoforms, CXCR4, and CXCR7 in The Cancer Genome Atlas breast cancer cohort using next-generation RNA sequencing in 948 breast cancer and benign samples and seven breast cancer cell lines. We compared expression levels with several clinical parameters, as well as metastasis, recurrence, and overall survival (OS). CXCL12-α, -β, and -γ are highly co-expressed, with low expression correlating with more aggressive subtypes, higher stage disease, and worse clinical outcomes. CXCL12-δ did not correlate with other isoforms but was prognostic for OS and showed the same trend for metastasis and recurrence-free survival. Effects of CXCL12-δ remained independently prognostic when taking into account expression of CXCL12,CXCR4, and CXCR7. These results were also reflected when comparing CXCL12-α, -β, and -γ in breast cancer cell lines. We summarized expression of all CXCL12 isoforms in an important chemokine signaling pathway in breast cancer in a large clinical cohort and common breast cancer cell lines, establishing differences among isoforms in multiple clinical, pathologic, and molecular subgroups. We identified for the first time the clinical importance of a previously unstudied isoform, CXCL12-δ.

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
Miguel Martín, Aleix Prat, +24 authors, Philip S Bernard.
Breast Cancer Res Treat, 2013 Feb 21; 138(2). PMID: 23423445    Free PMC article.
CXCR7 functions as a scavenger for CXCL12 and CXCL11.
Ulrike Naumann, Elisabetta Cameroni, +5 authors, Marcus Thelen.
PLoS One, 2010 Feb 18; 5(2). PMID: 20161793    Free PMC article.
Highly Cited.
CXCR4 regulates growth of both primary and metastatic breast cancer.
Matthew C P Smith, Kathryn E Luker, +4 authors, Gary D Luker.
Cancer Res, 2004 Dec 03; 64(23). PMID: 15574767
Highly Cited.
Regulation of apoptosis by alternative pre-mRNA splicing.
Christian Schwerk, Klaus Schulze-Osthoff.
Mol Cell, 2005 Jul 02; 19(1). PMID: 15989960
Highly Cited. Review.
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Zhenhua Miao, Kathryn E Luker, +9 authors, Thomas J Schall.
Proc Natl Acad Sci U S A, 2007 Sep 28; 104(40). PMID: 17898181    Free PMC article.
Highly Cited.
Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer.
Hua Kang, Gareth Watkins, +3 authors, Wen G Jiang.
Breast Cancer Res, 2005 Jul 01; 7(4). PMID: 15987445    Free PMC article.
Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.
Maria De La Luz Sierra, Fuquan Yang, +6 authors, Giovanna Tosato.
Blood, 2003 Oct 04; 103(7). PMID: 14525775
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses.
Christine Vogel, Edward M Marcotte.
Nat Rev Genet, 2012 Mar 14; 13(4). PMID: 22411467    Free PMC article.
Highly Cited. Review.
Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
M K Wendt, A N Cooper, M B Dwinell.
Oncogene, 2007 Aug 29; 27(10). PMID: 17724466
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Soluble CD44 splice variants in metastasizing human breast cancer.
S Martin, F Jansen, J Bokelmann, H Kolb.
Int J Cancer, 1997 Aug 22; 74(4). PMID: 9291436
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.
Michael R Ladomery, Steven J Harper, David O Bates.
Cancer Lett, 2006 Oct 10; 249(2). PMID: 17027147
Review.
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
Jennifer M Burns, Bretton C Summers, +12 authors, Thomas J Schall.
J Exp Med, 2006 Aug 31; 203(9). PMID: 16940167    Free PMC article.
Highly Cited.
TopHat: discovering splice junctions with RNA-Seq.
Cole Trapnell, Lior Pachter, Steven L Salzberg.
Bioinformatics, 2009 Mar 18; 25(9). PMID: 19289445    Free PMC article.
Highly Cited.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
Heather R Christofk, Matthew G Vander Heiden, +6 authors, Lewis C Cantley.
Nature, 2008 Mar 14; 452(7184). PMID: 18337823
Highly Cited.
Identification and expression of novel isoforms of human stromal cell-derived factor 1.
Lan Yu, Jeffrey Cecil, +5 authors, Jian Wang.
Gene, 2006 Apr 22; 374. PMID: 16626895
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer.
Ivan Babic, Erik S Anderson, +21 authors, Paul S Mischel.
Cell Metab, 2013 May 28; 17(6). PMID: 23707073    Free PMC article.
Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
Sudarshan Rajagopal, Jihee Kim, +5 authors, Robert J Lefkowitz.
Proc Natl Acad Sci U S A, 2009 Dec 19; 107(2). PMID: 20018651    Free PMC article.
Highly Cited.
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.
Cole Trapnell, Brian A Williams, +6 authors, Lior Pachter.
Nat Biotechnol, 2010 May 04; 28(5). PMID: 20436464    Free PMC article.
Highly Cited.
High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
Quyen D Chu, Lori Panu, +3 authors, Songlin Zhang.
J Surg Res, 2009 Jun 09; 159(2). PMID: 19500800
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer.
A Prat, J S Parker, C Fan, C M Perou.
Breast Cancer Res Treat, 2012 Jul 04; 135(1). PMID: 22752290    Free PMC article.
Misregulation of pre-mRNA alternative splicing in cancer.
Jian Zhang, James L Manley.
Cancer Discov, 2013 Oct 23; 3(11). PMID: 24145039    Free PMC article.
Highly Cited. Review.
The UCSC Cancer Genomics Browser: update 2013.
Mary Goldman, Brian Craft, +8 authors, Jingchun Zhu.
Nucleic Acids Res, 2012 Oct 31; 41(Database issue). PMID: 23109555    Free PMC article.
Highly Cited.
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
P Guo, L Xu, +9 authors, S Y Cheng.
Cancer Res, 2001 Dec 04; 61(23). PMID: 11731444
Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Rabia Sadir, Anne Imberty, Françoise Baleux, Hugues Lortat-Jacob.
J Biol Chem, 2004 Aug 05; 279(42). PMID: 15292258
Ensembl 2013.
Paul Flicek, Ikhlak Ahmed, +52 authors, Stephen M J Searle.
Nucleic Acids Res, 2012 Dec 04; 41(Database issue). PMID: 23203987    Free PMC article.
Highly Cited.
Global quantification of mammalian gene expression control.
Björn Schwanhäusser, Dorothea Busse, +5 authors, Matthias Selbach.
Nature, 2011 May 20; 473(7347). PMID: 21593866
Highly Cited.
Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.
Xiang H-F Zhang, Xin Jin, +6 authors, Joan Massagué.
Cell, 2013 Sep 03; 154(5). PMID: 23993096    Free PMC article.
Highly Cited.
Involvement of chemokine receptors in breast cancer metastasis.
A Müller, B Homey, +11 authors, A Zlotnik.
Nature, 2001 Mar 10; 410(6824). PMID: 11242036
Highly Cited.
Differential expression of SDF-1 isoforms in bladder cancer.
Miguel Gosalbez, Marie C Hupe, +7 authors, Vinata B Lokeshwar.
J Urol, 2013 Dec 03; 191(6). PMID: 24291546    Free PMC article.
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Alison L Allan, Rosamma George, +12 authors, Alan B Tuck.
Am J Pathol, 2006 Jul 04; 169(1). PMID: 16816376    Free PMC article.
Pyruvate kinase M2 is a phosphotyrosine-binding protein.
Heather R Christofk, Matthew G Vander Heiden, +2 authors, Lewis C Cantley.
Nature, 2008 Mar 14; 452(7184). PMID: 18337815
Highly Cited.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Alternative splicing: an emerging topic in molecular and clinical oncology.
María J Pajares, Teresa Ezponda, +3 authors, Luis M Montuenga.
Lancet Oncol, 2007 Mar 31; 8(4). PMID: 17395108
Review.
Proteolytic processing of SDF-1α by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration.
Hui Peng, Yumei Wu, +2 authors, Jialin C Zheng.
Protein Cell, 2012 Nov 13; 3(11). PMID: 23143873    Free PMC article.
Alternative isoform regulation in human tissue transcriptomes.
Eric T Wang, Rickard Sandberg, +6 authors, Christopher B Burge.
Nature, 2008 Nov 04; 456(7221). PMID: 18978772    Free PMC article.
Highly Cited.
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype.
S Chekhun, N Bezdenezhnykh, J Shvets, N Lukianova.
Exp Oncol, 2013 Oct 03; 35(3). PMID: 24084454
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Valentina Mirisola, Ambra Zuccarino, +4 authors, Ulrich Pfeffer.
Eur J Cancer, 2009 Aug 04; 45(14). PMID: 19646861
Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells.
M A Matrone, R A Whipple, +8 authors, S S Martin.
Oncogene, 2010 Mar 17; 29(22). PMID: 20228842    Free PMC article.
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins.
Patricia Rueda, Karl Balabanian, +14 authors, Fernando Arenzana-Seisdedos.
PLoS One, 2008 Jul 24; 3(7). PMID: 18648536    Free PMC article.
Hallmarks of alternative splicing in cancer.
S Oltean, D O Bates.
Oncogene, 2013 Dec 18; 33(46). PMID: 24336324
Highly Cited. Review.
Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature, 2012 Sep 25; 490(7418). PMID: 23000897    Free PMC article.
Highly Cited.
Comparative analysis of proteome and transcriptome variation in mouse.
Anatole Ghazalpour, Brian Bennett, +23 authors, Aldons J Lusis.
PLoS Genet, 2011 Jun 23; 7(6). PMID: 21695224    Free PMC article.
Highly Cited.
CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?
Dan G Duda, Sergey V Kozin, +3 authors, Rakesh K Jain.
Clin Cancer Res, 2011 Feb 26; 17(8). PMID: 21349998    Free PMC article.
Highly Cited. Review.
CXCL12 (SDF-1)/CXCR4 pathway in cancer.
Beverly A Teicher, Simon P Fricker.
Clin Cancer Res, 2010 May 21; 16(11). PMID: 20484021
Highly Cited. Review.
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Neslihan Cabioglu, Aysegul Sahin, +8 authors, Janet E Price.
Clin Exp Metastasis, 2005 Sep 01; 22(1). PMID: 16132577
Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.
Patricia Rueda, Adèle Richart, +9 authors, Jean-Sébastien Silvestre.
Circulation, 2012 Oct 05; 126(15). PMID: 23035208    Free PMC article.
CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
M Hofmann, W Rudy, +4 authors, U Günthert.
Cancer Res, 1991 Oct 01; 51(19). PMID: 1717145
Highly Cited.
Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis.
S P Cavnar, P Ray, +5 authors, G D Luker.
Integr Biol (Camb), 2014 Mar 29; 6(5). PMID: 24675873    Free PMC article.
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
Qun Pan, Ofer Shai, +2 authors, Benjamin J Blencowe.
Nat Genet, 2008 Nov 04; 40(12). PMID: 18978789
Highly Cited.
Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs.
Tereza Lopotová, Jaroslav Polák, +2 authors, Jana Moravcová.
Blood Cells Mol Dis, 2012 May 05; 49(1). PMID: 22555024
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, +20 authors, Breast Cancer Intergroup of North America.
Lancet Oncol, 2009 Dec 17; 11(1). PMID: 20005174    Free PMC article.
Highly Cited.
Development and preclinical characterization of a humanized antibody targeting CXCL12.
Cuiling Zhong, Jianyong Wang, +21 authors, Napoleone Ferrara.
Clin Cancer Res, 2013 Jul 03; 19(16). PMID: 23812669
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
Xueqing Sun, Guangcun Cheng, +6 authors, Jianhua Wang.
Cancer Metastasis Rev, 2010 Sep 15; 29(4). PMID: 20839032    Free PMC article.
Highly Cited. Review.
Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Neal T Holm, Kerry Byrnes, +4 authors, Quyen D Chu.
J Surg Res, 2007 Jun 19; 141(1). PMID: 17574038
Alternative splicing and genomic structure of the Wilms tumor gene WT1.
D A Haber, R L Sohn, +3 authors, D E Housman.
Proc Natl Acad Sci U S A, 1991 Nov 01; 88(21). PMID: 1658787    Free PMC article.
Highly Cited.
Splice variants as cancer biomarkers.
Brigitta M N Brinkman.
Clin Biochem, 2004 Jul 06; 37(7). PMID: 15234240
Review.
Molecular characterization of the tumor microenvironment in breast cancer.
Minna Allinen, Rameen Beroukhim, +10 authors, Kornelia Polyak.
Cancer Cell, 2004 Jul 21; 6(1). PMID: 15261139
Highly Cited.
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
Dawid G Nowak, Elianna Mohamed Amin, +8 authors, David O Bates.
J Biol Chem, 2009 Nov 13; 285(8). PMID: 19906640    Free PMC article.
Highly Cited.
SDF1β expression in renal cell carcinoma correlates with grading and infiltration by CD8+ T-cells.
T C Wehler, C Graf, +8 authors, C C Schimanski.
Anticancer Res, 2011 Aug 27; 31(9). PMID: 21868522
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
Akira Orimo, Piyush B Gupta, +6 authors, Robert A Weinberg.
Cell, 2005 May 11; 121(3). PMID: 15882617
Highly Cited.
A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.
Jeffrey D Altenburg, Hal E Broxmeyer, +3 authors, Ghalib Alkhatib.
J Virol, 2007 May 18; 81(15). PMID: 17507482    Free PMC article.
Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.
Adedayo A Onitilo, Jessica M Engel, Robert T Greenlee, Bickol N Mukesh.
Clin Med Res, 2009 Jul 04; 7(1-2). PMID: 19574486    Free PMC article.
Highly Cited.
Cell, isoform, and environment factors shape gradients and modulate chemotaxis.
S Laura Chang, Stephen P Cavnar, +2 authors, Jennifer J Linderman.
PLoS One, 2015 Apr 25; 10(4). PMID: 25909600    Free PMC article.
Development and validation of a novel platform-independent metastasis signature in human breast cancer.
Shuang G Zhao, Mark Shilkrut, +5 authors, Felix Y Feng.
PLoS One, 2015 May 15; 10(5). PMID: 25974184    Free PMC article.
Inhibiting the mobilization of Ly6C(high) monocytes after acute myocardial infarction enhances the efficiency of mesenchymal stromal cell transplantation and curbs myocardial remodeling.
Wenbin Lu, Yong Tang, +5 authors, Genshan Ma.
Am J Transl Res, 2015 Jun 06; 7(3). PMID: 26045897    Free PMC article.
Alternative splicing as a biomarker and potential target for drug discovery.
Kai-qin Le, Bellur S Prabhakar, Wan-jin Hong, Liang-cheng Li.
Acta Pharmacol Sin, 2015 Jun 16; 36(10). PMID: 26073330    Free PMC article.
Review.
Endothelial CXCR7 regulates breast cancer metastasis.
A C Stacer, J Fenner, +6 authors, G D Luker.
Oncogene, 2015 Jun 30; 35(13). PMID: 26119946    Free PMC article.
Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model.
Claudia Tulotta, Cristina Stefanescu, +4 authors, B Ewa Snaar-Jagalska.
Dis Model Mech, 2016 Jan 09; 9(2). PMID: 26744352    Free PMC article.
A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.
Babak Behnam Azad, Samit Chatterjee, +5 authors, Sridhar Nimmagadda.
Oncotarget, 2016 Feb 06; 7(11). PMID: 26848769    Free PMC article.
Gene Expression Profiling of Breast Cancer Brain Metastasis.
Ji Yun Lee, Kyunghee Park, +11 authors, Yeon Hee Park.
Sci Rep, 2016 Jun 25; 6. PMID: 27340107    Free PMC article.
Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.
Trung Nghia Vu, Setia Pramana, +3 authors, Yudi Pawitan.
Oncotarget, 2016 Sep 17; 7(42). PMID: 27634900    Free PMC article.
Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Chun-Yao Li, Dan-Dan Xiong, +7 authors, Gang Chen.
Med Sci Monit, 2017 Apr 19; 23. PMID: 28416776    Free PMC article.
IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.
Y Qiao, C Zhang, +20 authors, Y Zhang.
Oncogene, 2017 Oct 24; 37(7). PMID: 29059160
Highly Cited.
The CXCL12/CXCR7 signaling axis, isoforms, circadian rhythms, and tumor cellular composition dictate gradients in tissue.
Phillip C Spinosa, Kathryn E Luker, Gary D Luker, Jennifer J Linderman.
PLoS One, 2017 Nov 09; 12(11). PMID: 29117251    Free PMC article.
Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Yongfu Xiong, Ying Deng, +4 authors, Zhongxue Fu.
EBioMedicine, 2018 Sep 24; 36. PMID: 30243491    Free PMC article.
Highly Cited.
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes.
Younghun Jung, Frank C Cackowski, +11 authors, Russell S Taichman.
Cancer Res, 2018 Feb 13; 78(8). PMID: 29431639    Free PMC article.
Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer.
Manish Charan, Ajeet K Verma, +6 authors, Ramesh K Ganju.
Int J Mol Sci, 2020 Aug 23; 21(16). PMID: 32824813    Free PMC article.
Review.
CXCL12γ induces human prostate and mammary gland development.
Younghun Jung, Jin Koo Kim, +4 authors, Russell S Taichman.
Prostate, 2020 Jul 14; 80(13). PMID: 32659025    Free PMC article.
CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?
Alessandra Righetti, Matteo Giulietti, +3 authors, Francesco Piva.
J Oncol, 2019 Jul 06; 2019. PMID: 31275385    Free PMC article.
Review.
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
Babak Behnam Azad, Ala Lisok, +5 authors, Sridhar Nimmagadda.
J Nucl Med, 2016 Feb 26; 57(6). PMID: 26912435    Free PMC article.
Three-dimensional tumor model mimics stromal - breast cancer cells signaling.
Stephanie Lemmo Ham, Pradip Shahi Thakuri, +4 authors, Hossein Tavana.
Oncotarget, 2018 Feb 09; 9(1). PMID: 29416611    Free PMC article.